Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Brello Health vs NuviaRx

By GLP-1 ScorecardUpdated

Brello Health
Site position #373

Lower score

NuviaRxFactor scores not reassessed.
Site position #75

Higher score

Score comparison

NuviaRx has the higher recorded score — 73.5/100 to 59.4/100.

NuviaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuviaRx is a GLP-1 weight-loss telehealth service offering compounded semaglutide (from $140/mo) and tirzepatide (from $170/mo) with transparent pricing and free delivery.

Before you choose

Before comparing the headline prices, the Brello Health review and the NuviaRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Brello Health vs Ondra Health and CoreAge Rx vs NuviaRx compare each of them with another graded program, and the list of alternatives to Brello Health ranks the programs closest to Brello Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the MyDrHank review covers one graded close to these two, at 68.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNuviaRx +42
45
87
Dose & formulationNuviaRx +8
64
72
Clinical oversightNuviaRx +10
72
82
Labs & monitoringEven
53
53
FulfillmentBrello Health +1
73
72
Contract termsNuviaRx +2
53
55
Brello Health · top barNuviaRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBrello HealthNuviaRx
WeighScore59.4/10073.5/100
GradeCC
Site position#373#75
Semaglutide$399 per advertised 3-month supply; renews every 11 weeks ($133/mo equivalent)$140/mo (all doses, compounded)
Tirzepatide$499 per advertised 3-month supply, every 11 weeks; $894 per 6-month supply, every 22 weeks$170/mo (all doses, compounded)
CoverageCheck state availabilityCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Brello Health

Site position #373 · C

Strengths

  • Publicly lists both compounded medication programs
  • Plans include fitness and nutrition classes plus support

What to consider

  • Multi-month upfront purchase
  • Three-month plans renew every eleven weeks, not a calendar quarter
  • Published post-approval refund instructions differ on deadline and contact method
NuviaRx

Site position #75 · C

Factor scores not reassessed.

Strengths

  • Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
  • Free delivery included; clinical evaluation and prescription bundled (if eligible)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
  • Named operating entity (NuviaRx Health Inc.) with a US address and phone support

What to consider

  • Compounding pharmacy partner not named ('partner pharmacy')
  • LegitScript certification was not documented on the public pages reviewed
  • Lowest pricing is 'as low as' — likely requires a longer prepaid plan
  • State availability not published

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard